José Iglesias

José has an over 30 years’ career in the pharmaceutical Industry, both in large pharma and biotech, and has wide experience in designing and leading all Phases (I-IV) of oncology clinical trials, including 3 large Phase III registration studies. José has occupied leadership and senior management positions (CMO, SVP, VP) with department-founding duties in clinical development and medical affairs. Whilst serving as Vice President, Clinical Development, at Celgene Corporation, he was responsible for the Phase III development of Abraxane in pancreatic cancer, lung cancer and metastatic breast cancer. José is author or co-author of more than 60 publications in the area of Oncology, with over 9,000 citations. He is an active member of the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR) and the European Society of Medical Oncology (ESMO).